Providence Health Care
Results of world’s first study on new treatment for heroin addiction
The results of a ground-breaking SALOME research shows chronic heroin addiction now has another effective treatment tool – hydromorphone, a licensed pain medication.
Apr 6, 2016
Researchers sound warning over heart attack symptoms
New study findings warn the public and physicians that relying on traditional symptoms for heart attacks in young people and women can lead to dangerous misdiagnoses.
Sep 17, 2013
New hospice opening at UBC Vancouver
St. John Hospice, a new comprehensive palliative care facility in Vancouver providing 14 bedrooms for individuals in need of end-of-life care, officially opened today.
Sep 6, 2013
Q&A on medical ethics
Prof. Anita Ho tackles complex ethical matters such as assisted suicide, in vitro fertilization and private healthcare.
Jul 23, 2013
Dr. James Hogg given national award for leadership in medicine
The Gairdner Foundation has recognized Dr. James Hogg with the Canada Gairdner Wightman Award, the premier honour for leadership in medical science in Canada.
Mar 20, 2013
HIV/AIDS Treatment as Prevention strategy working in B.C. Montaner calls for national implementation
A new study from the BC Centre for Excellence in HIV/AIDS (BC-CfE) shows highly active antiretroviral therapy (HAART) reduces new HIV diagnoses, deaths and HIV prevalence, suggesting that the made-in-Canada Treatment as Prevention strategy should be implemented across the country.
Nov 27, 2012
New UBC professorship focuses on women's cardiovascular health
The first research program in British Columbia to focus on gender-based differences in cardiovascular disease has been established by the University of British Columbia and Providence Health Care.
Oct 19, 2011
UBC-Providence Health research to examine new treatments for heroin addiction
A clinical trial to test better treatment options for chronic heroin addiction is expected to begin in Vancouver at the end of this year. Led by researchers from Providence Health Care and the University of British Columbia, it’s the only clinical trial of its kind in North America.
Oct 12, 2011